Stay updated on pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.

Latest updates to the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page
- Check4 days agoChange DetectedThe NCT03600350 record for a prostate cancer trial is displayed instead of an access-error page, with study details, participation criteria, treatment plan, and outcome measures.SummaryDifference53%

- Check11 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA site-wide NIH notice about terminology changes appears above the page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study page now returns a 403 Forbidden error, replacing the detailed study record with an access-denied page. This prevents users from viewing the NCT03600350 study details and related information.SummaryDifference19%

- Check60 days agoChange DetectedA new revision note, v3.7.0, was added and the older revision note v3.6.6 was removed. The Prostate cancer topic and the related topics tag MedlinePlus Genetics were removed, indicating an update to metadata rather than core content.SummaryDifference0.2%

Stay in the know with updates to pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.